Skip to content
2000
Volume 20, Issue 6
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Cancer is one of the prominent global causes of death and the foremost worldwide health concern. Despite unprecedented progress in cancer chemoprevention, a vast number of cancers, however, remain an undefeatable challenge for treatment modalities. Immense therapeutic activities of puerarin contribute to its use in various health disorders. In this review, we explored the potential molecular mechanisms and targets of puerarin, proving its potential as a novel anticancer agent, for future cancer therapy and chemoprevention. Several mechanisms account for anticancer activity of puerarin which includes downregulation of NF-kB signalling pathway, mTOR signalling pathway, PI3K and BCl-2 proteins and upregulation of miR-16, caspase proteins, c- Jun N terminal kinase and extracellular signal-regulated kinase 1/2. These alterations result in inhibition of cancer cell proliferation and/or induction of apoptosis. Understanding the molecular mechanisms involved in chemotherapy and chemoprevention could aid in the more pronounced exploration of puerarin in effective cancer treatment.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/1871520620666200227091811
2020-04-01
2025-04-09
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/1871520620666200227091811
Loading

  • Article Type:
    Review Article
Keyword(s): adjuvant; chemoprevention; isoflavones; neoplasms; polyphenols; Puerarin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test